IL50631A - 1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them - Google Patents

1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them

Info

Publication number
IL50631A
IL50631A IL50631A IL5063176A IL50631A IL 50631 A IL50631 A IL 50631A IL 50631 A IL50631 A IL 50631A IL 5063176 A IL5063176 A IL 5063176A IL 50631 A IL50631 A IL 50631A
Authority
IL
Israel
Prior art keywords
benzazolylalkyl
piperidines
substituted
preparation
pharmaceutical compositions
Prior art date
Application number
IL50631A
Other languages
English (en)
Other versions
IL50631A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL50631A0 publication Critical patent/IL50631A0/xx
Publication of IL50631A publication Critical patent/IL50631A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL50631A 1975-10-08 1976-10-07 1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them IL50631A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62072775A 1975-10-08 1975-10-08
US05/713,309 US4035369A (en) 1975-10-08 1976-08-10 1-Benzazolylalkyl-4-substituted-piperidines

Publications (2)

Publication Number Publication Date
IL50631A0 IL50631A0 (en) 1976-12-31
IL50631A true IL50631A (en) 1980-02-29

Family

ID=27088773

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50631A IL50631A (en) 1975-10-08 1976-10-07 1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them

Country Status (31)

Country Link
US (1) US4035369A (sv)
JP (1) JPS5246082A (sv)
AT (1) AT365185B (sv)
AU (1) AU511834B2 (sv)
BG (1) BG27542A3 (sv)
CA (1) CA1085853A (sv)
CH (1) CH630915A5 (sv)
CS (1) CS225101B2 (sv)
DE (1) DE2645125A1 (sv)
DK (1) DK151801C (sv)
EG (1) EG12969A (sv)
ES (1) ES452200A1 (sv)
FI (1) FI63228C (sv)
FR (1) FR2346009A1 (sv)
GB (1) GB1532546A (sv)
GR (1) GR61672B (sv)
HU (1) HU174927B (sv)
IE (1) IE43951B1 (sv)
IL (1) IL50631A (sv)
IT (1) IT1069293B (sv)
LU (1) LU75954A1 (sv)
NL (1) NL7611085A (sv)
NO (1) NO144926C (sv)
NZ (1) NZ182134A (sv)
PH (1) PH15417A (sv)
PL (1) PL106815B1 (sv)
PT (1) PT65688B (sv)
RO (1) RO69904A (sv)
SE (1) SE417610B (sv)
SU (1) SU663306A3 (sv)
YU (1) YU39976B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
IE810250L (en) * 1980-02-11 1981-08-11 Berlex Lab N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines.
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
DE3442757A1 (de) * 1984-11-23 1986-05-28 Wella Ag, 6100 Darmstadt Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
FR2702214B1 (fr) * 1993-03-05 1995-04-14 Adir Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
GB9418326D0 (en) * 1994-09-12 1994-11-02 Lilly Industries Ltd Pharmaceutical compounds
EP0705832B1 (en) 1994-09-12 2003-08-13 Eli Lilly And Company Limited Serotonergic modulators
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
GB9613423D0 (en) * 1996-06-26 1996-08-28 Lilly Industries Ltd Pharmaceutical compounds
EP2392584A1 (en) * 2006-09-19 2011-12-07 Cipla Limited Crystalline Ciclesonide Methanol Solvate Form C
CN101759693B (zh) * 2008-12-23 2011-09-14 江苏恩华药业股份有限公司 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用
WO2022195102A1 (en) * 2021-03-19 2022-09-22 Centre National De La Recherche Scientifique Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (sv) * 1962-06-13
US3225052A (en) * 1964-05-06 1965-12-21 Janssen Pharmaceutica Nv Benzimidazolinyl piperidine derivatives
FR1573739A (sv) 1968-07-26 1969-07-04
US3647790A (en) * 1969-04-08 1972-03-07 American Home Prod Ouinoxalinyl-oxazolidines and -oxazines

Also Published As

Publication number Publication date
NZ182134A (en) 1979-01-11
GB1532546A (en) 1978-11-15
AT365185B (de) 1981-12-28
CS225101B2 (en) 1984-02-13
DK151801C (da) 1988-06-06
JPS6215553B2 (sv) 1987-04-08
FI63228C (fi) 1983-05-10
LU75954A1 (sv) 1977-05-09
IL50631A0 (en) 1976-12-31
FI762865A (sv) 1977-04-09
PT65688A (en) 1976-11-01
PL192890A1 (pl) 1978-03-28
ATA745276A (de) 1981-05-15
PH15417A (en) 1983-01-07
ES452200A1 (es) 1978-01-16
SE417610B (sv) 1981-03-30
IE43951L (en) 1977-04-08
NO144926C (no) 1981-12-09
PT65688B (en) 1978-04-02
AU511834B2 (en) 1980-09-11
JPS5246082A (en) 1977-04-12
FI63228B (fi) 1983-01-31
AU1807876A (en) 1978-04-06
FR2346009B1 (sv) 1978-12-22
CA1085853A (en) 1980-09-16
IE43951B1 (en) 1981-07-01
IT1069293B (it) 1985-03-25
DK151801B (da) 1988-01-04
FR2346009A1 (fr) 1977-10-28
BG27542A3 (en) 1979-11-12
NO144926B (no) 1981-08-31
EG12969A (en) 1981-03-31
CH630915A5 (de) 1982-07-15
GR61672B (en) 1978-12-05
NL7611085A (nl) 1977-04-13
DE2645125A1 (de) 1977-04-21
YU39976B (en) 1985-06-30
NO763424L (sv) 1977-04-13
DK452076A (da) 1977-04-09
US4035369A (en) 1977-07-12
SU663306A3 (ru) 1979-05-15
DE2645125C2 (sv) 1988-11-24
RO69904A (fr) 1980-08-15
SE7611137L (sv) 1977-04-09
YU248076A (en) 1983-01-21
PL106815B1 (pl) 1980-01-31
HU174927B (hu) 1980-04-28

Similar Documents

Publication Publication Date Title
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL50632A0 (en) Pyridinyl-2(1h)-pyridinones their preparation and pharmaceutical compositions containing them
IL50815A0 (en) New aminobenzoamides their preparation and pharmaceutical compositions containing them
IL51660A0 (en) Hentriakontapeptides their preparation and pharmaceutical compositions containing them
IL53043A0 (en) Novel 1-aryloxy-2-hydroxy-3-aminopropane - derivatives their preparation and pharmaceutical compositions containing them
IL51087A0 (en) New polyhalogeno-steroids their manufacture and pharmaceutical compositions containing them
ZA763917B (en) Pharmaceutical compositions and compounds
IL50631A (en) 1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL47329A (en) Pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
IL52137A0 (en) Novel aryltrifluoroethylamines their preparation and pharmaceutical compositions containing them
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
IL50522A0 (en) Novel n-aryl-n-(4-piperidinyl)-arylacetamides their preparation and pharmaceutical compositions containing them
IL50335A (en) Diphenylalkylpolyamine derivatives,their preparation and pharmaceutical compositions containing them
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
IL51468A0 (en) Novel d-homosteroids their preparation and pharmaceutical compositions containing them
IL53026A0 (en) New pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
IL50554A (en) 2,9-dioxatricyclodecanes,their preparation and pharmaceutical compositions containing them
IL50945A0 (en) Novel cephalosporins their preparation and pharmaceutical compositions containing them
IL52006A0 (en) Novel nephthalene derivatives their preparation and pharmaceutical compositions containing them